...
首页> 外文期刊>Case Reports in Cardiology >Emergency Valve-in-Valve Transcatheter Aortic Valve Implantation for the Treatment of Acute Stentless Bioprosthetic Aortic Insufficiency and Cardiogenic Shock
【24h】

Emergency Valve-in-Valve Transcatheter Aortic Valve Implantation for the Treatment of Acute Stentless Bioprosthetic Aortic Insufficiency and Cardiogenic Shock

机译:紧急瓣膜导管主动脉瓣植入术治疗急性无支架生物假体主动脉瓣关闭不全和心源性休克

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Bioprosthetic aortic valve degeneration may present as acute, severe aortic regurgitation and cardiogenic shock. Such patients may be unsuitable for emergency valve replacement surgery due to excessive risk of operative mortality but could be treatable with transfemoral valve-in-valve transcatheter aortic valve implantation (TAVI). There is a paucity of data regarding the feasibility of valve-in-valve TAVI in patients presenting with cardiogenic shock due to acute aortic insufficiency from stentless bioprosthetic valve degeneration. We present one such case, highlighting the unique aspects of valve-in-valve TAVI for this challenging patient subset.
机译:生物人工主动脉瓣变性可能表现为急性,严重的主动脉瓣反流和心源性休克。由于手术死亡率过高的风险,此类患者可能不适合进行紧急瓣膜置换手术,但经股动脉瓣膜内瓣膜导管主动脉瓣植入术(TAVI)可以治疗。由于无支架生物人工瓣膜变性导致的急性主动脉瓣关闭不全而导致心源性休克的患者中,瓣膜瓣膜TAVI的可行性尚缺乏数据。我们介绍了一个这样的案例,重点介绍了该具有挑战性的患者子集的瓣膜内TAVI的独特方面。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号